Supplemental Reading for Chapter 1 Basic Principles of Clinical ...

A preliminary report. Br J Clin Pharmacol 24:343,
1987.
401 Bensenor IM, Lotufo PA: Headache, hypertension,
and irbesartan therapy. Arch Intern Med 161:775–
776, 2001.
402. Etminan M, Levine MA, Tomlinson G, Rochon
PA: Efficacy of angiotensin II receptor antagonists
in preventing headache: A systematic overview and
meta-analysis. Am J Med 112:642, 2002.
403. Weber MA, Messerli FH: Angiotensin converting
enzyme inhibitors and angioedema. Estimating the
risk. Hypertension 51: 1465, 2008.
404. Herkner H, Temmel AF, Mullner M, et al: Different
patterns of angioedema in patients with and
without angiotensin-converting enzyme inhibitor
therapy. Wien Klin Wochenschr 113:167, 2001.
405. Vleeming W, van Amsterdam JG, Stricker BH, et
al: ACE inhibitor-induced angioedema. Drug Saf
18:171, 1998.
406. Brown NJ, Snowden M, Griffin MR: Recurrent angiotensin-converting
enzyme inhibitor-associated
angioedema. JAMA 278:232, 1997.
407. Dobbels P, Van Overbeke L, Vanbeckevoort D,
Hiele M. Acute abdomen due to intestinal angioedema
induced by ACE inhibitors: not so rare?
Acta Gastroenterol Belg 72:455, 2009.
408. Haymore BR, Yoon J, Mikita CP, et al. Risk of angioedema
with angiotensin receptor blockers in
patients with prior angioedema associated with
angiotensin-converting enzyme inhibitors: a metaanalysis.
Ann Allergy Asthma Immunol 101:495,
2008.
409. Warner KK, Visconti JA, Tschampel MM: Angiotensin
II receptor blockers in patients with ACE
inhibitor-induced angioedema. Ann Pharmacother
34:526, 2000.
410. Sica DA, Black HR. Current concepts of pharmacotherapy
in hypertension: ACE inhibitor-related
angioedema: can angiotensin-receptor blockers be
safely used? J Clin Hypertens (Greenwich) 4:375,
2002.
411. Cohen DL, Townsend RR: Can an angiotensin receptor
blocker be used in a patient in whom angioedema
developed with an angiotensin converting
enzyme inhibitor? J Clin Hypertens 10: 949, 2008.
412. Quan A. Fetopathy associated with exposure to angiotensin
converting enzyme inhibitors and angiotensin
receptor antagonists. Early Hum Dev 82:23,
2006.
413. Lambot MA, Vermeylen D, Noel JC: Angiotensin-II-receptor
inhibitors in pregnancy. Lancet
357:1619, 2001.
References to Chapter 9 9-17
414. Burrows RF, Burrows EA: Assessing the teratogenic
potential of angiotensin-converting enzyme
inhibitors in pregnancy. Aust N Z J Obstet Gynaecol
38:306, 1998.
415. Cooper WO, Hernandez-Diaz S, Arbogast PG, et
al. Major congenital malformations after first-trimester
exposure to ACE inhibitors. N Engl J Med
354:2443, 2006.
416. Magee LA: Treating hypertension in women of
childbearing age and during pregnancy. Drug Saf
24:457, 2001.
417. Martin U, Foreman MA, Travis JC, et al. Use of
ACE inhibitors and ARBs in hypertensive women
of childbearing age. J Clin Pharm Ther 33:507,
2008.
418. Shannon ME, Malecha SE, Cha AJ: Angiotensinconverting
enzyme inhibitors and angiotensin II
receptor blockers and lactation: an update. J Hum
Lact 16:152, 2000.
419. Zwanzger P, Marcuse A, Boerner RJ, et al: Lithium
intoxication after administration of AT1 blockers. J
Clin Psychiatry 62:208, 2001.
420. Juurlink DN, Mamdani MM, Kopp A, et al. Druginduced
lithium toxicity in the elderly: a population-based
study. J Am Geriatr Soc 52:794, 2004.
421. Indermitte J, Burkolter S, Drewe J, et al. Risk factors
associated with a high velocity of the development
of hyperkalaemia in hospitalised patients. Drug Saf
30:71, 2007.
422. Conlin PR, Moore TJ, Swartz SL, et al: Effect of
indomethacin on blood pressure lowering by captopril
and losartan in hypertensive patients. Hypertension
36:461, 2000.
423. Fricker AF, Nussberger J, Meilenbrock S, et al: Effect
of indomethacin on the renal response to angiotensin
II receptor blockade in healthy subjects.
Kidney Int 54: 2089, 1998.
424. Pavlicević I, Kuzmanić M, Rumboldt M, Rumboldt
Z. Interaction between antihypertensives and
NSAIDs in primary care: a controlled trial. Can J
Clin Pharmacol 15:e372, 2008.
425. Adhiyaman V, Asghar M, Oke A, et al: Nephrotoxicity
in the elderly due to co-prescription of
angiotensin-converting enzyme inhibitors and
nonsteroidal anti-inflammatory drugs. J R Soc Med
94:512, 2001.
426. Samanta A, Burden AC: Fever, myalgia, and arthralgia
in a patient on captopril and allopurinol.
Lancet 1:679,1984.